Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Scp 776

Next Previous
Drug Profile

Scp 776

Alternative Names: Scp-776

Latest Information Update: 06 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Silver Creek Pharmaceuticals
  • Class Heart failure therapies; Neuroprotectants; Recombinant fusion proteins; Urologics; Vascular disorder therapies
  • Mechanism of Action Growth factor receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Ischaemic stroke
  • Phase I Brain injuries; Myocardial infarction
  • Preclinical Acute lung injury; Heart failure; Kidney disorders

Most Recent Events

  • 23 Oct 2025 Efficacy and adverse events data from a phase-II RPEGGIO trial in Ischaemic stroke released by Silver Creek Pharmaceuticals
  • 17 Oct 2025 Scp 776 receives Fast Track designation for Ischaemic stroke [IV,Injection] in USA
  • 17 Oct 2025 Silver Creek Pharmaceuticals completes enrolment in the phase IIa/IIb ARPEGGIO trial for acute Ischaemic stroke in USA (IV) (NCT05585606)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top